• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡莫司汀(BCNU)化疗后慢性肺纤维化:影像学特征

Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.

作者信息

Taylor P M, O'Driscoll B R, Gattamaneni H R, Woodcock A A

机构信息

Department of Diagnostic Radiology, University of Manchester.

出版信息

Clin Radiol. 1991 Nov;44(5):299-301. doi: 10.1016/s0009-9260(05)81262-0.

DOI:10.1016/s0009-9260(05)81262-0
PMID:1760904
Abstract

Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern.

摘要

卡莫司汀(BCNU)是一种细胞毒性药物,是公认的急性肺纤维化病因。我们描述了6例儿童期因治疗中枢神经系统肿瘤接受卡莫司汀治疗、随后在治疗后13至17年被发现患有肺纤维化的患者的影像学表现。通过胸部X线摄影和高分辨率计算机断层扫描对患者进行了研究。疾病模式很新颖,主要以外周型累及上肺区。

相似文献

1
Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.卡莫司汀(BCNU)化疗后慢性肺纤维化:影像学特征
Clin Radiol. 1991 Nov;44(5):299-301. doi: 10.1016/s0009-9260(05)81262-0.
2
Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.儿童期接受卡莫司汀(BCNU)化疗后长达17年出现的活动性肺纤维化。
N Engl J Med. 1990 Aug 9;323(6):378-82. doi: 10.1056/NEJM199008093230604.
3
Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
Mayo Clin Proc. 2003 May;78(5):630-4. doi: 10.4065/78.5.630.
4
Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.卡氮芥所致晚期肺损伤:卡氮芥对肺实质延迟效应的光镜与超微结构研究
J Pathol. 1991 May;164(1):31-6. doi: 10.1002/path.1711640106.
5
Chemotherapy-induced fatal pulmonary fibrosis.化疗诱发的致命性肺纤维化。
Neoplasma. 1984;31(6):739-44.
6
Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.低剂量1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀)治疗后发生的肺纤维化
Cancer. 1980 Mar 15;45(6):1311-4. doi: 10.1002/1097-0142(19800315)45:6<1311::aid-cncr2820450607>3.0.co;2-u.
7
[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].与卡氮芥联合化疗期间的进行性肺纤维化(作者译)
Blut. 1978 Jun 20;36(6):353-6. doi: 10.1007/BF01000593.
8
Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.双氯亚硝脲的肺毒性:一例对皮质类固醇治疗有短暂反应的病例报告。
Cancer. 1979 May;43(5):1607-12. doi: 10.1002/1097-0142(197905)43:5<1607::aid-cncr2820430507>3.0.co;2-0.
9
Pulmonary toxicity from carmustine (BCNU): a case report.卡莫司汀(BCNU)引起的肺毒性:一例报告。
Med Pediatr Oncol. 1979;6(3):255-9. doi: 10.1002/mpo.2950060310.
10
Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.肺纤维化:1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀)治疗的一种并发症。
Cancer. 1981 Aug 15;48(4):909-11. doi: 10.1002/1097-0142(19810815)48:4<909::aid-cncr2820480408>3.0.co;2-6.